Nanomaterials (NMs) have been increasingly used in a number of areas, including consumer products and nanomedicine. Target tissue dosimetry is important in the evaluation …
W Utembe, H Clewell, N Sanabria, P Doganis… - Nanomaterials, 2020 - mdpi.com
There have been efforts to develop physiologically based pharmacokinetic (PBPK) models for nanomaterials (NMs). Since NMs have quite different kinetic behaviors, the applicability …
EO Kutumova, IR Akberdin, IN Kiselev… - International Journal of …, 2022 - mdpi.com
Cancer treatment and pharmaceutical development require targeted treatment and less toxic therapeutic intervention to achieve real progress against this disease. In this scenario …
Fragmentation of plastic waste in the environment can lead to the formation of nanoscale plastic debris (NPD) of size< 1 μm. Although it is reported that NPD can be taken up by …
O Ozbek, DE Genc, K O. Ulgen - ACS Pharmacology & …, 2024 - ACS Publications
Nanoparticles (NPs) have been widely used to improve the pharmacokinetic properties and tissue distribution of small molecules such as targeting to a specific tissue of interest …
AP Klapproth, M Shevtsov, S Stangl, WB Li… - International Journal …, 2020 - Taylor & Francis
Background Superparamagnetic iron oxide nanoparticles (SPIONs) have displayed multifunctional applications in cancer theranostics following systemic delivery. In an effort to …
C Flexner, M Siccardi, F Bunglawala… - Clinical Infectious …, 2022 - academic.oup.com
Developing long-acting products and formulations for infectious diseases is a nontrivial undertaking that is frequently classified as high risk and low reward by the pharmaceutical …
Background: In-vivo CRISPR Cas genome editing is a complex therapy involving lipid nanoparticle (LNP), messenger RNA (mRNA), and single guide RNA (sgRNA). This novel …
The experimental determination of bioaccumulation is challenging, and a number of approaches have been developed for its prediction. It is important to assess the applicability …